Skip to main content
. Author manuscript; available in PMC: 2016 Aug 30.
Published in final edited form as: Eur J Pharm Sci. 2015 Apr 28;76:1–9. doi: 10.1016/j.ejps.2015.04.024

Table 3.

Glass transition temperatures and drug melting temperatures observed in the formulations

Formulation Tg (°C) Tm (°C)
 R1-B 38.3 N/A
 R1-5 38.2 BDLa
 R1-10 40.2 129.5
 R1-20 41.9 149.4
 R2-B 39.1 N/A
 R2-5 38.4 164.7
 R2-10 39.8 145.8
 R2-20 38.4 155.9
 R3-B 37.4 N/A
 R3-5 35.5 146.8
 R3-10 42.1 160.3
 R3-20 43.8 170.0
a

BDL = below detectable limit